Micronoma Puts Machine Learning to Work

It’s no exaggeration to say the development of Micronoma’s Oncobiota™ microbiome-driven liquid-biopsy technology to detect cancer at an early stage would not be possible without extensive expertise and use of machine learning (ML) tools.  Micronoma’s proprietary...

Team Spotlight: Chuck Rosales, Quality Manager

Chuck Rosales joined Micronoma in July 2021 as the quality manager, responsible for implementing and maintaining all compliance and quality procedures to ensure that patient testing is performed with the highest standards. Though born in Kansas, he has lived in San...

Why is Clonal Evolution Still a Sterile Theory?

Despite major revelations in the science of cancer, a classic theory of how it develops—clonal evolution—has remained a perplexing vestige of ‘sterile’ cancer biology.  Arguing against the sterility of tumors, the last decade of research has revealed metabolically...

Hallmarks of Cancer Update Sharpens Focus on Micronoma’s Work

Inclusion of microbiome supports Micronoma’s efforts to improve cancer detection The “hallmarks of cancer” have captured the core features of cancer biology and served as a guide for future research since their original publication in Cell in 2000. Since then, the...

Team Spotlight: Gabriella Fanelli

Gabriella Fanelli, Executive Assistant Gabriella joined Micronoma in the Spring of 2021. Gabriella makes everything at Micronoma run smoothly and efficiently. As the only person on the team who’s not science-focused – she was an English literature major in...

Team Spotlight: Akanksha Singh-Taylor

Akanksha Singh-Taylor, Senior Scientist Akanksha Singh-Taylor joined Micronoma in September 2021 as a senior scientist on our wet lab side. Originally from Delhi, India, Akanksha moved to Houston when she was 10. During her work with children and adults with severe...